eSignal IPO Calendar

Week of Expected Pricing	Pending
Company Name	PROCESSA PHARMACEUTICALS INC
Proposed Ticker	N/A
CUSIP	74275C106
Business Description	an emerging clinical stage biopharmaceutical company focused on the development of drug products that are intended to provide treatment for and improve the survival and/or quality of life of patients who have a high unmet medical need condition or who have no alternative treatment.
Lead Underwriter	N/A
Co-Managers	N/A
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A